190 related articles for article (PubMed ID: 37958435)
1. Special Issue Editorial: Emerging Therapies in Renal Cell Carcinoma: The Road to a Cure?
Campbell MT; Zhang T
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958435
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapeutic approaches in renal cell carcinoma.
Parekh H; Rini BI
Expert Rev Anticancer Ther; 2015; 15(11):1305-14. PubMed ID: 26376584
[TBL] [Abstract][Full Text] [Related]
3. Challenges and advances in the diagnosis, biology, and treatment of urothelial upper tract and bladder carcinomas.
Aragon-Ching JB
Urol Oncol; 2017 Jul; 35(7):462-464. PubMed ID: 28625477
[TBL] [Abstract][Full Text] [Related]
4. Renal cystic diseases and renal neoplasms: a mini-review.
Bonsib SM
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1998-2007. PubMed ID: 19875768
[TBL] [Abstract][Full Text] [Related]
5. [Targeted treatment of renal cell carcinoma, treatment caused side-effects and side-effect management].
Nagyiványi K; Géczi L
Orv Hetil; 2017 Sep; 158(38):1488-1502. PubMed ID: 28920717
[TBL] [Abstract][Full Text] [Related]
6. An update on the pathology of collecting duct & papillary renal cell carcinoma with a discussion of SNP-Arrays as an emerging laboratory technique.
Gupta S
Urol Oncol; 2022 Dec; 40(12):497-498. PubMed ID: 34127371
[TBL] [Abstract][Full Text] [Related]
7. Signaling inhibitors in metastatic renal cell carcinoma.
Escudier B
Cancer J; 2008; 14(5):325-9. PubMed ID: 18836338
[TBL] [Abstract][Full Text] [Related]
8. Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma.
Jian Y; Yang K; Sun X; Zhao J; Huang K; Aldanakh A; Xu Z; Wu H; Xu Q; Zhang L; Xu C; Yang D; Wang S
Front Immunol; 2021; 12():639636. PubMed ID: 33767709
[TBL] [Abstract][Full Text] [Related]
9. Emerging research methods and their application to road safety.
Tarko A; Boyle LN; Montella A
Accid Anal Prev; 2013 Dec; 61():1-2. PubMed ID: 23896448
[TBL] [Abstract][Full Text] [Related]
10. Editorial for special issue on advances in Actuarial Science and quantitative finance.
Feng R; Figueroa-López JE; Guo J; Lefèvre C
Methodol Comput Appl Probab; 2022; 24(2):475-479. PubMed ID: 35692561
[TBL] [Abstract][Full Text] [Related]
11. Molecular-based therapies for renal cell carcinoma.
Zisman A; Pantuck AJ; Belldegrun AS
Curr Urol Rep; 2001 Feb; 2(1):55-61. PubMed ID: 12084296
[TBL] [Abstract][Full Text] [Related]
12. Skeletal metastasis in renal cell carcinoma: A review.
Umer M; Mohib Y; Atif M; Nazim M
Ann Med Surg (Lond); 2018 Mar; 27():9-16. PubMed ID: 29511536
[TBL] [Abstract][Full Text] [Related]
13. The Past, Present and Future of Immunotherapy for Metastatic Renal Cell Carcinoma.
Chang AJ; Zhao L; Zhu Z; Boulanger K; Xiao H; Wakefield MR; Bai Q; Fang Y
Anticancer Res; 2019 Jun; 39(6):2683-2687. PubMed ID: 31177102
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma.
Rini BI; Campbell SC; Rathmell WK
Curr Opin Oncol; 2006 May; 18(3):289-96. PubMed ID: 16552243
[TBL] [Abstract][Full Text] [Related]
15. An Overview of Systemic Targeted Therapy in Renal Cell Carcinoma, with a Focus on Metastatic Renal Cell Carcinoma and Brain Metastases.
Semenescu LE; Kamel A; Ciubotaru V; Baez-Rodriguez SM; Furtos M; Costachi A; Dricu A; Tătăranu LG
Curr Issues Mol Biol; 2023 Sep; 45(9):7680-7704. PubMed ID: 37754269
[TBL] [Abstract][Full Text] [Related]
16. Editorial of Special Issue "New Aspects of the Hepatocyte Growth Factor/c-Met System".
Ricci G
Biomedicines; 2015 Jun; 3(2):201-202. PubMed ID: 28536407
[TBL] [Abstract][Full Text] [Related]
17. Using cumulative toxicity to identify the optimal second-line targeted therapy in patients with metastatic renal cell carcinoma: what's new?
Di Lorenzo G; De Placido S
Future Oncol; 2014 Apr; 10(5):845-50. PubMed ID: 24341421
[TBL] [Abstract][Full Text] [Related]
18. Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice.
Salgia M; Adashek J; Bergerot P; Pal SK
Kidney Cancer; 2017 Nov; 1(2):99-105. PubMed ID: 30334011
[TBL] [Abstract][Full Text] [Related]
19. Stem cell therapy for neurodegenerative diseases: the issue of transdifferentiation.
Cova L; Ratti A; Volta M; Fogh I; Cardin V; Corbo M; Silani V
Stem Cells Dev; 2004 Feb; 13(1):121-31. PubMed ID: 15068700
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives.
Larroquette M; Peyraud F; Domblides C; Lefort F; Bernhard JC; Ravaud A; Gross-Goupil M
Cancer Treat Rev; 2021 Jun; 97():102207. PubMed ID: 33906023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
